Instrument Inactif

Autres langues Synthorx, Inc.

Actions

US87167A1034

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Synthorx, Inc.(NasdaqGS:THOR) dropped from S&P Global BMI Index	24/01/20
Synthorx, Inc.(NasdaqGM:THOR) dropped from S&P TMI Index	24/01/20
SYNTHORX, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23/01/20
Synthorx, Inc. Announces Executive Changes	23/01/20
Synthorx, Inc.(NasdaqGS:THOR) dropped from NASDAQ Composite Index	23/01/20
Sanofi completed the acquisition of Synthorx, Inc. from Avalon Ventures, LLC, Correlation Ventures, OrbiMed Advisors LLC, Medicxi Ventures (UK) LLP and others.	23/01/20
Sanofi : - Hart-Scott-Rodino waiting period expires for Sanofi :'s acquisition of Synthorx	21/01/20
Tesla gets Chinese boost, Boeing’s new troubles, scandal for Tesco…	23/12/19
WeissLaw LLP Investigates Synthorx, Inc.	12/12/19
Sanofi : to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion	10/12/19
Synthorx : Sanofi shares rally on new margin goals, narrower drug focus	10/12/19
Novartis : Sanofi gibt Diabetes-Forschung auf	10/12/19
Synthorx : Sanofi ends research in diabetes, narrows units to spur profit	09/12/19
Synthorx : Drug giant Sanofi to buy U.S. biotech firm Synthorx for $2.5B	09/12/19
European shares dragged down by Tullow Oil and weak China export data	09/12/19
SYNTHORX, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	09/12/19
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	09/12/19
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	09/12/19
Sanofi : kauft US-Krebsspezialisten für 2,5 Milliarden Dollar	09/12/19
Sanofi will mit Milliarden-Zukauf in den USA Krebsgeschäft ausbauen	09/12/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Synthorx, Inc.

Actions

US87167A1034

Autres langues

Filtres